Behrouz Hassannia
Gent, VLG, Belgium
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications
Author Correction: Targeting ferroptosis protects against experimental (multi)organ dysfunction and death.
Journal: Nature communications
Published: September 18, 2025
Dual lipid modulation overcomes ferroptosis resistance in high-risk neuroblastoma.
Journal: Cell death and differentiation
Published: June 06, 2025
Oxazole-Based Ferroptosis Inhibitors with Promising Properties to Treat Central Nervous System Diseases.
Journal: Journal of medicinal chemistry
Published: February 06, 2025
Harnessing ferroptosis for precision oncology: challenges and prospects.
Journal: BMC biology
Published: November 28, 2024
Ferroptosis is a targetable detrimental factor in metabolic dysfunction-associated steatotic liver disease.
Journal: Cell death and differentiation
Published: May 28, 2024
Improving cardiac differentiation of human pluripotent stem cells by targeting ferroptosis.
Journal: Regenerative therapy
Published: December 20, 2023
Beyond ferrostatin-1: a comprehensive review of ferroptosis inhibitors.
Journal: Trends in pharmacological sciences
Published: July 24, 2023
Ferroptosis contributes to multiple sclerosis and its pharmacological targeting suppresses experimental disease progression.
Journal: Cell death and differentiation
Published: April 19, 2023
Molecular Mechanisms of Nemorosone-Induced Ferroptosis in Cancer Cells.
Journal: Cells
Published: December 16, 2022
Correction to: Luminescent Human iPSC-Derived Neurospheroids Enable Modeling of Neurotoxicity After Oxygen-glucose Deprivation.
Journal: Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics
Published: June 21, 2022
Last Updated: 09/26/2026